Catheter ablation of atrial fibrillation in heart failure reduces mortality and hospitalization: The CASTLE-AF trialFebruary 20, 2018
Compared with medical therapy alone, catheter ablation of atrial fibrillation in patients with heart failure reduced the risk for all-cause mortality and hospitalization.
Patients with persistent atrial fibrillation who received targeted therapy saw improvements in sinus rhythm as well as reductions in blood pressure, cholesterol, and weight.
A 45-year-old man presents to the emergency department with some mental confusion and near syncope.
Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.
A 35-year-old pregnant woman presents to the emergency department with progressive dyspnea and palpitations that have worsened during the last 3 weeks.
Migraine was associated with elevated risks of myocardial infarction, stroke (ischemic and hemorrhagic), venous thromboembolism, and atrial fibrillation or flutter.
Catheter ablation was associated with a significant reduction in a composite end point of death from any cause or hospitalization for worsening heart failure in patients with atrial fibrillation.
The next best diagnostic step in the workup of acute ischemic stroke in context of updated 2018 guidelines is discussed.
Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.
Uninterrupted and minimally interrupted apixaban are associated with low rates of thromboembolic events in patients undergoing catheter ablation for nonvalvular afib.
Current evidence is inadequate to assess benefits and harms of ECG screening for atrial fibrillation.
Cost-effective DOACs like apixaban prevent strokes better than warfarin in patients with atrial fibrillation.
Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial FibrillationDecember 15, 2017
In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.
In patients with atrial fibrillation, in-hospital mortality is higher in rural hospitals vs urban hospitals.
Four clinical bleeding risk scores are able to identify the atrial fibrillation patients who are at risk for major bleeding.
Patients who had short-run atrial tachyarrhythmia experienced significantly higher rates of stroke compared with patients who did not have short-run atrial tachyarrhythmia.
In patients with new-onset atrial fibrillation, cardiologist care is associated with lower rates of death.
Patients with atrial fibrillation who are treated with oral anticoagulants often experience renal function decline.
The chemical stability of warfarin sodium tablets is not affected by repackaging into dose administration aids.
No significant association was found between atrial fibrillation risk and leukocyte telomere length.
FDA has cleared the KardiaBand device to recordtheir EKG to detect normal heart rhythms and atrial fibrillation.
Antithrombotic Therapy for Atrial Fibrillation and Valvular Heart Disease: New Joint Consensus StatementDecember 05, 2017
A new consensus statement provides updated guidelines for antithrombotic therapy in patients with atrial fibrillation associated with valvular heart disease.
The American College of Cardiology released an expert consensus decision pathway intended to guide clinicians in managing bleeding in patients treated with anticoagulation.
Ablation is associated with reduced risk of recurrent stroke in patients with atrial fibrillation.
A 46-year-old obese man with a history of hypertension and hyperlipidemia presents to the emergency department with worsening palpitations.
Continuous monitoring with an insertable cardiac monitor was found to be superior at detecting subclinical atrial fibrillation compared with a Holter monitor.
The 10 mg dose of rivaroxaban substantially lowered the risk for recurrent venous thromboembolism.
A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.
Risk prediction models to assess bleeding risk in patients with atrial fibrillation may be useful for optimizing treatment.
Optimal treatment strategies for lone atrial fibrillation have been unclear, but more technological advances and understanding of disease are propelling researchers forward.
The Cardiology Advisor Articles
- A 45-Year-Old Man Presents to the ED With Shortness of Breath, Confusion
- A 56-Year-Old Man With Flu-Like Symptoms Presents With Palpitations
- Acute Coronary Syndrome Benefits From Both Antiplatelets and DOACs
- 6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH
- Fear of E-Cigarette Harm Cuts Teenagers' Use
- Clopidogrel Tablets Recalled Due to Mislabeling
- Mandatory Screening for Congenital Heart Disease: Effects on Infant Mortality
- Short-Run Atrial Tachyarrhythmia Associated With Increased Stroke Risk
- Effects of High-Intensity Exercise Training in Previously Sedentary Adults
- ACC Releases Decision Pathway on Heart Failure With Reduced Ejection Fraction
- Clinical Challenge: Upper Respiratory Infection 1 Year After Heart Transplant
- Use of Multiple Antihypertensive Agents Has Increased in Hospitalizations Complicated by Preeclampsia
- Targeting Underlying Conditions May Improve Sinus Rhythm in Atrial Fibrillation
- Metformin May Preserve Beta-Cell Function in T2DM
- A 67-Year-Old Man With Shortness of Breath After the Sonoma-Napa Wildfires